significant increase and breakthrough infections and hospitalizations and deaths. is there evidence of significant increase in these breakthrough hospitalizations and deaths and can you pointtous that evidence? are you seeing that? you look at the evidence from the cohorts here in the united states. there s no doubt there s a diminution of the efficacy of the vaccine in infection. there s a slight suggestion in a couple of the cohorts that it s true for diminution of protection against hospitalization. not profound but the suggestion when you look at the data is there. however, when you lookt at the israeli data and they are about a month or so in every aspect of us in the vaccination, boosters, et cetera. the data is there s a
which it very much seems to be in the initial signal, the question is how long does that protection really last? because if it s a very short-term effect, essentially, yao just bought a few weeks of time or a few months, but if it s a long-term effect, then they re on to something, especially in that 60-plus subset that has been studied. so there s a lot to tease out, that i fear has not yet been. and dr., in some parts of the country, new cases are continuing to climb. you see it on your screen there, of the delta variant obviously a huge issue, and we re still in the middle of a wave of new cases. i m curiouses as to what you re seeing in your emergency room, in your hospital. well, here in the state and write work, we are seeing some breakthrough cases, but most of the hospitalizations remain in the unvaccinated. our state is now tracking breakthrough infections and breakthrough hospitalizations and breakthrough deaths. and i had a chance to really get into that data the past co
fading with time, especially after six months? certainly with the pfizer vaccine, i am. as i said, the data looks like it s going down from over 90% to 40 to 50%. but before you panic, remember, the vast majority of those breakthrough cases are without symptoms or very mild symptoms. what we re not really seeing, we don t think, are breakthrough hospitalizations. on the other hand, we re not seeing a lot of data presented by the cdc. so for instance, it would be nice if we had a breakdown of all major medical centers in the united states, knowing the percentage of hospitalized individuals who were vaccinated versus unvaccinated. that might help. but we haven t seen it. hopefully that data will be forthcoming. so yes, we are seeing a decline in protection. it may be the tip of the spear for breakthrough hospitalizations. we haven t seen that yet. so no need to panic. but we will need a third immunization, i think. a clear and important distinction. dr. peter hotez, appreciate your
one of the problems, though, is most of the data is not publicly available, and it s coming out in dribs and drabs. we re seeing some information from israel showing that the protection against infection has gone down from over 90% to 40 to 50% for infection. but it s not clear whether we re seeing breakthrough hospitalizations. so this is all going to come to a head on september 17. the vrbpac committee will have a chance to fully review the data and we ll see the data as well and get some clarity on this. that was interesting, dr. fauci did mention, i think it was thursday, this israel study, that showed for more than a million people 16 and older, their relative risk of infection went down by 11-fold, 12 days after getting the booster. do we know more about the safety data in terms of any bad side effects from a third shot? so far i ve not seen any red
four weeks apart because we were in crisis, we were losing 3,000 american lives a day, we had to get everybody fully vaccinated. but when you do that kind of schedule, it almost guarantees that you will have waning immunity at some point. and that s the reason why it became a three-dose vaccine. the other piece, though, is we haven t seen whether we re really seeing breakthrough hospitalizations. yet we are seeing a lot of breakthrough infections, efficacy s declining from over 90% to 40 to 50%. do we need to see that decline in hospitalizations as well? or because of the longhaul covid that we are seeing among breakthrough unvaccinated cases. so the acip which met today only set aside a small amount of time for these questions. pfizer s just recently applied for it. so i think this will come up at the next acip meeting. pfizer today indicated that it will submit vaccine data for children ages 5 to 11 in